Abstract
The emergence of nosocomial infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) has prompted research directed at the development of novel antibacterial agents to treat these diseases. This review will examine the literature on anti-MRSA and anti-VRE antibacterial research published between 2001 and October 2006.
Keywords: Chloroorienticin B, quinolone, natural products, linezolid, bacterial cell wall
Related Journals
Current Medicinal Chemistry
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Current HIV Research
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Related Books
COVID-19: Causes, Transmission, Diagnosis, and Treatment
Herbal Medicine for Autoimmune Diseases
Infectious Diseases
Emerging Approaches to Tackle Neglected Diseases: From Molecule to End Product
The NLRP3 Inflammasome: An Attentive Arbiter of Inflammatory Response
Marine Biopharmaceuticals: Scope and Prospects
COVID 19 – Monitoring with IoT Devices
Frontiers in Clinical Drug Research-Anti Infectives
Recent Advances in the Application of Marine Natural Products as Antimicrobial Agents
Recent Trends and The Future of Antimicrobial Agents - Part 2
5